Saland J. Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?
Pediatr Nephrol 2014;
29:329-32. [PMID:
24362724 DOI:
10.1007/s00467-013-2722-2]
[Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/19/2013] [Revised: 11/19/2013] [Accepted: 12/03/2013] [Indexed: 02/06/2023]
Abstract
Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.
Collapse